Cargando…
Correction: The risk of newly diagnosed cancer in patients with rheumatoid arthritis by TNF inhibitor use: a nationwide cohort study
Autores principales: | Choi, Boyoon, Park, Hyun Jin, Song, Yun-Kyoung, Oh, Yoon-Jeong, Kim, In-Wha, Oh, Jung Mi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594875/ https://www.ncbi.nlm.nih.gov/pubmed/36284316 http://dx.doi.org/10.1186/s13075-022-02929-0 |
Ejemplares similares
-
The risk of newly diagnosed cancer in patients with rheumatoid arthritis by TNF inhibitor use: a nationwide cohort study
por: Choi, Boyoon, et al.
Publicado: (2022) -
Association of Tumor Necrosis Factor Inhibitors with the Risk of Nontuberculous Mycobacterial Infection in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study
por: Park, Hyun Jin, et al.
Publicado: (2023) -
Correction to: Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment
por: Oliver, James, et al.
Publicado: (2021) -
Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2019) -
Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis
por: Cho, Soo-Kyung, et al.
Publicado: (2016)